CClinicalTrials.gg
RecruitingNCT07122245Updated Aug 18, 2026

Demographics of Lung Cancer in Females

An observational study in Lung Cancer, sponsored by Mansoura University Hospital. Recruiting at 1 site in Egypt. Open to female participants. Per ClinicalTrials.gov, last updated 2026-08-18.

Sponsored by Mansoura University Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
300
Sex
Female
01

Study summary

Lung cancer has been the most common and fatal type of cancer; indeed worldwide incidence of lung cancer is alarming. It is considered a leading cause of cancer- related deaths among males and females due to environmental pollution, occupational exposure, genetic susceptibility, increasing number of smokers and others.

Read the detailed description

Lung cancer has been the most common and fatal type of cancer; indeed worldwide incidence of lung cancer is alarming. It is considered a leading cause of cancer- related deaths among males and females due to environmental pollution, occupational exposure, genetic susceptibility, increasing number of smokers and others.

Moreover, a large proportion of people living in low and middle income countries are exposed to secondhand smoke (SHS) in their homes, workplaces, and other public places.

Although, lung cancer had become one of fatality causes of the 20th century due to an increasing life span combined with exposures to various etiologic factors, it is one of the leading causes of preventable deaths.

There are various important risk factors other than tobacco smoking that can contribute substantially to the lung cancer mortality in never smokers; these other lung carcinogens often act in an additive or synergistic manner in individuals who smoke tobacco products.

02

Conditions studied

  • Lung Cancer

Browse trials for

Keywords

  • Demographics
  • lung cancer
  • female patients
03

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

A retrospective cohort study will be conducted on bronchogenic carcinoma patients who had been presented to and diagnosed at chest diseases department, Oncology Center Mansoura University (OCMU) in last 10 years.

Inclusion criteria

  • All female patients presented with bronchogenic carcinoma patients and diagnosed at chest diseases department, Oncology Center Mansoura University (OCMU) in last 10 years.

Exclusion criteria

Exclusion Criteria:

  • lung metastasis ( not primary bronchogenic carcinoma)
04

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
300 participants (estimated)
Patient registry
No

Groups and cohorts

  • bronchogenic carcinoma in female patients

    A retrospective cohort study will be conducted on bronchogenic carcinoma female patients who had been presented to and diagnosed at chest diseases department, Oncology Center Mansoura University (OCMU).

    Behavioral: Demographics and risk factors of lung cancer

Interventions

  • BehavioralDemographics and risk factors of lung cancer

    A retrospective cohort study will be conducted on bronchogenic carcinoma patients who had been presented to and diagnosed at chest diseases department, Oncology Center Mansoura University (OCMU).

05

What researchers measure

Primary outcomes

  1. Risk factors of lung cancer in females

    A retrospective cohort study will be conducted on bronchogenic carcinoma patients who had been presented to and diagnosed at chest diseases department, Oncology Center Mansoura University (OCMU) in last 10 years.

    Time frame: 6 months

06

Study locations

1 of 1 sites recruiting
  • Mohamed AbdElmoniem
    Al Mansurah, 35516, Egypt
    Recruiting
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07122245
Lead sponsor
Mansoura University Hospital
Responsible party
Mohamed Abd Elmoniem Mohamed (Lecturer of chest medicine faculty of medicine, Mansoura University Hospital) — Principal investigator
First posted
Aug 14, 2025
Start date
Aug 7, 2025
Primary completion
Dec 7, 2026 (estimated)
Completion
Apr 7, 2027 (estimated)
Last update
Aug 18, 2026

Study contacts

Mohamed AbdElmoniem
Contact
dr.m1993@mans.edu.eg
01014008473
Mohamed Mansour
Contact
01014008473
Mohamed AbdElmoniem
principal investigator · Lecturer of chest medicine faculty of medicine Mansoura university

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion